| Complement-binding anti-HLA antibodies and kidney-allograft survival A Loupy, C Lefaucheur, D Vernerey, C Prugger, JPD van Huyen, ... New England Journal of Medicine 369 (13), 1215-1226, 2013 | 960 | 2013 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| MicroRNA expression profiles predictive of human renal allograft status D Anglicheau, VK Sharma, R Ding, A Hummel, C Snopkowski, ... Proceedings of the National Academy of Sciences 106 (13), 5330-5335, 2009 | 428 | 2009 |
| Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies A Loupy, C Suberbielle-Boissel, GS Hill, C Lefaucheur, D Anglicheau, ... American Journal of Transplantation 9 (11), 2561-2570, 2009 | 412 | 2009 |
| Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes D Joly, D Anglicheau, C Alberti, AT Nguyen, M Touam, JP Grünfeld, ... Journal of the American Society of Nephrology 14 (4), 1012-1021, 2003 | 400 | 2003 |
| Antibody-mediated vascular rejection of kidney allografts: a population-based study C Lefaucheur, A Loupy, D Vernerey, JP Duong-Van-Huyen, C Suberbielle, ... The Lancet 381 (9863), 313-319, 2013 | 397 | 2013 |
| Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients12 E Thervet, D Anglicheau, B King, MH Schlageter, B Cassinat, P Beaune, ... Transplantation 76 (8), 1233-1235, 2003 | 372 | 2003 |
| Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients D Anglicheau, P Laurent-Puig, L Becquemont, B Cassinat, P Beaune, ... Journal of the American Society of Nephrology 14 (7), 1889-1896, 2003 | 372 | 2003 |
| Analyses of the short-and long-term graft survival after kidney transplantation in Europe between 1986 and 2015 M Coemans, C Süsal, B Döhler, D Anglicheau, M Giral, O Bestard, ... Kidney international 94 (5), 964-973, 2018 | 292 | 2018 |
| An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants S Caillard, D Anglicheau, M Matignon, A Durrbach, C Greze, L Frimat, ... Kidney international 98 (6), 1549-1558, 2020 | 285 | 2020 |
| Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor‐specific antibodies (DSA) A Loupy, GS Hill, C Suberbielle, D Charron, D Anglicheau, J Zuber, ... American Journal of Transplantation 11 (1), 56-65, 2011 | 282 | 2011 |
| Is COVID‐19 infection more severe in kidney transplant recipients? S Caillard, N Chavarot, H Francois, M Matignon, C Greze, N Kamar, ... American Journal of Transplantation 21 (3), 1295-1303, 2021 | 266 | 2021 |
| CYP3A5 and MDR1 Genetic Polymorphisms and Cyclosporine Pharmacokinetics After Renal Transplantation D Anglicheau, E Thervet, I Etienne, B Hurault De Ligny, Y Le Meur, ... Clinical Pharmacology & Therapeutics 75 (5), 422-433, 2004 | 254 | 2004 |
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation M Delville, TK Sigdel, C Wei, J Li, SC Hsieh, A Fornoni, GW Burke, ... Science translational medicine 6 (256), 256ra136-256ra136, 2014 | 242 | 2014 |
| Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation D Anglicheau, M Flamant, MH Schlageter, F Martinez, B Cassinat, ... Nephrology Dialysis Transplantation 18 (11), 2409-2414, 2003 | 228 | 2003 |
| MicroRNAs: small RNAs with big effects D Anglicheau, T Muthukumar, M Suthanthiran Transplantation 90 (2), 105-112, 2010 | 192 | 2010 |
| Autophagy protects renal tubular cells against cyclosporine toxicity N Pallet, N Bouvier, C Legendre, J Gilleron, P Codogno, P Beaune, ... Autophagy 4 (6), 783-791, 2008 | 187 | 2008 |
| Early epithelial phenotypic changes predict graft fibrosis A Hertig, D Anglicheau, N Pallet, M Touzot, PY Ancel, L Mesnard, ... Journal of the American Society of Nephrology 19 (8), 1584-1591, 2008 | 184 | 2008 |
| Sirolimus may reduce fertility in male renal transplant recipients J Zuber, D Anglicheau, C Elie, L Bererhi, MO Timsit, MF Mamzer‐Bruneel, ... American Journal of Transplantation 8 (7), 1471-1479, 2008 | 181 | 2008 |
| Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy D Anglicheau, D Le Corre, S Lechaton, P Laurent-Puig, H Kreis, ... American Journal of Transplantation 5 (3), 595-603, 2005 | 179 | 2005 |
Maarten NaesensProfessor, Department of Microbiology, Immunology & Transplantation, KU LeuvenCorreu electrònic verificat a uzleuven.be
